Other

SKYRIZI

SKYRIZI (risankizumab-rzaa) is an intravenous prescription medicine used for the treatment of moderately to severely active Crohn’s disease.
Infusion or injection therapy referral
What it treats Crohn’s Disease
Prescribed by Various medical specialists
How it’s administered Intravenous (IV) infusion
Frequency Week zero, week four, then every 12 weeks thereafter
Length of treatment About one hour

About This Therapy

SKYRIZI (risankizumab-rzaa) is an intravenous prescription medicine used for the treatment of moderately to severely active Crohn’s disease.

For more information, visit the patient website for this drug. Speak with your healthcare provider to learn if this drug is right for you.

SKYRIZI REFERRAL FORM

SKYRIZI REFERRAL FORM

Speak with your healthcare provider to learn if this therapy is right for you, then complete the referral form below.

Ready to refer a patient for SKYRIZI

Our team handles benefits verification, prior authorization, and scheduling so you can focus on care.